Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels
<p><strong>Introduction:</strong><br /> The lack of approved specific therapeutic agents to treat coronavirus disease (COVID‐19) associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has led to the rapid implementation of convalescent plasma t...
Huvudupphovsmän: | Harvala, H, Robb, ML, Watkins, N, Ijaz, S, Dicks, S, Patel, M, Supasa, P, Wanwisa, D, Liu, C, Mongkolsapaya, J, Bown, A, Bailey, D, Vipond, R, Grayson, N, Temperton, N, Gupta, S, Ploeg, RJ, Bolton, J, Fyfe, A, Gopal, R, Simmonds, P, Screaton, G, Thompson, C, Brooks, T, Zambon, M, Miflin, G, Roberts, DJ |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
Wiley
2020
|
Liknande verk
Liknande verk
-
The molecular reach of antibodies crucially underpins their viral neutralisation capacity
av: Anna Huhn, et al.
Publicerad: (2025-01-01) -
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
av: Thompson, CP, et al.
Publicerad: (2020) -
Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
av: Emma M. Bentley, et al.
Publicerad: (2021-08-01) -
Heterologous SARS‐CoV‐2 IgA neutralising antibody responses in convalescent plasma
av: Samantha K Davis, et al.
Publicerad: (2022-01-01) -
Effects of SARS-CoV-2 strain variation on virus neutralisation titres: therapeutic use of convalescent plasma
av: Nguyen, D, et al.
Publicerad: (2021)